OCA transplantation can be effective treatment option for active patients with knee cartilage injuries

NewsGuard 100/100 Score

For athletes and highly active patients who sustain cartilage injuries to their knee, an osteochondral allograft transplantation can be a successful treatment option, according to research presented today at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting in Colorado Springs, CO. The study showed these patients were consistently able to return to sport or recreational activities after the surgery, though frequently at a lower activity level.

"We examined the success of osteochondral allograft (OCA) transplantation in 149 knees, and found 113, or 76% of those treated with the surgery, had returned to activity at an average follow-up of 6 years," commented William Bugbee, MD, lead author from the Scripps Clinic in La Jolla, CA. "Patients who are highly active can be discouraged by these types of injuries, so we are happy to see the success of this treatment option."

An OCA involves transplantation of donated osteochondral tissue to a defect in the recipient patient's knee joint. In this study, the average age of the subjects was 31 years old, with 59% being male. While the study showed positive statistics relating to general return to activity, only 28% returned at the same level pre-injury, and 48% returned to one or more but not all of the same sports and activities.

"We also saw an overall 90% survivorship of the transplanted grafts at a 6-year follow-up," noted Bugbee. "This presents further evidence that the procedure, especially in those individuals who are highly active, can be positive for recovery and future athletic goals."

This study adds to previous research which shows long-term functional improvement in knees after OCA transplant.

Source: American Orthopaedic Society for Sports Medicine (AOSSM)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Epilepsy drug may alleviate joint degeneration associated with osteoarthritis